Dual agonism activates two hormone pathways, typically producing greater weight loss and glycemic benefit than single-target GLP-1 therapy in clinical trials
For statistical comparisons between two groups, we employed an unpaired two-tailed t test in GraphPad (Prism)
Some users describe the sensation as similar to how they felt in their twenties, with thoughts flowing more easily and concentration requiring less effort
In unweighted UniFrac beta-diversity analysis, 1,25(OH) 2 D emerged as the most significant predictor, accounting for 2% of the variation
In a pilot study testing BSO/melphalan in 32 children with neuroblastoma, some tumors got smaller, however, 2 children died from decreased function of the kidneys combined with brain swelling